US 11045443
Glutaminase inhibitor therapy
granted A61KA61K31/282A61K31/337
Quick answer
US patent 11045443 (Glutaminase inhibitor therapy) held by The Board of Regents of the University of Texas System expires Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jun 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K31/282, A61K31/337, A61K31/4196, A61K31/433